Host: |
Goat |
Applications: |
Pep-ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-TOX3 (N-Term) is suitable for use in ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
ELISA-antibody detection limit dilution 1:128000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
TOX3 |
Gene ID: |
27324 |
Uniprot ID: |
TOX3_HUMAN |
Immunogen Region: |
N-Term |
Accession Number: |
NP_001073899.2 |
Immunogen Sequence: |
AGDPASLDFAQC |
Function | Transcriptional coactivator of the p300/CBP-mediated transcription complex. Activates transactivation through cAMP response element (CRE) sites. Protects against cell death by inducing antiapoptotic and repressing pro-apoptotic transcripts. Stimulates transcription from the estrogen-responsive or BCL-2 promoters. Required for depolarization-induced transcription activation of the C-FOS promoter in neurons. Associates with chromatin to the estrogen-responsive C3 promoter region. |
Protein Name | Tox High Mobility Group Box Family Member 3Cag Trinucleotide Repeat-Containing Gene F9 ProteinTrinucleotide Repeat-Containing Gene 9 Protein |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Tox High Mobility Group Box Family Member 3 antibodyAnti-Cag Trinucleotide Repeat-Containing Gene F9 Protein antibodyAnti-Trinucleotide Repeat-Containing Gene 9 Protein antibodyAnti-TOX3 antibodyAnti-CAGF9 antibodyAnti-TNRC9 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance